WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'8701 Infant (under 12 months) mortality rate: 222
GDP / capita (US$): 14'6871 Child (under 5 years) mortality rate: 262

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 40'606  39'872  39'113  38'339  37'566  31'184  25'912  19'338 
Births 935  949  957  956  946  610  832  839 
Surviving infants 912  925  931  930  920  586  790  763 
Pop. less than 5 years 4'699  4'664  4'596  4'491  4'340  3'088  3'994  3'528 
Pop. less than 15 years 11'778  11'424  11'070  10'721  10'393  10'687  11'230  8'948 
Female 15-49 years 10'790  10'731  10'666  10'589  10'496  8'341  5'935  4'185 

Number of reported cases

(Click for retrospective incidence data for Algeria)
Diphtheria
ChartChart
  30  116 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  41  63  25  18  1'796  15'527 
Mumps
ChartChart
  67  27 
Pertussis
ChartChart
  69  104  23  710 
Polio*
ChartChart
  116 
Rubella
ChartChart
  13  414  420 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  27 
Tetanus (total)**
ChartChart
  38  86 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Algeria)
Vaccine year result method % card seen                                                
BCG 2011  98  MICS   92  99*  99*  99*  99*  99*  65 
DTP1 2011  97  MICS   92  99*  99*  99*  99*  99* 
DTP3 2011  91  MICS   92  95  95  95  95  95  58 
DTP4          95  95 
IPV1          99*  99* 
HepB_BD          99*  99*  99*  99*  99* 
HepB3 2011  89  MICS   92  95  95  95  95  95 
Hib3 2011  91  MICS   92  95  95  95  95  95 
JapEnc         
MCV1          95  95  95  95  95  80  53 
MCV2          98  99*  99*  93  95 
MenA         
PCV1          95 
PCV2          95 
PCV3          95 
Pol3 2011  91  MICS   92  95  95  95  95  95  81 
Rota1         
RotaC         
RCV1         
TT2plus 2011  33  MICS   92 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Algeria)
BCG
ChartChart
  99  99  99  99  99  97  99 
DTP1
ChartChart
  96  99  99  99  99  95  96 
DTP3
ChartChart
  91  95  95  95  95  86  89 
HepB3
ChartChart
  91  95  95  95  95 
HepB_BD
ChartChart
  99  99  99  99  99 
Hib3
ChartChart
  91  95  95  95  95 
IPV1
  94 
MCV1
ChartChart
  94  95  95  95  95  80  83 
MCV2
ChartChart
  96  99  99  93  95  78 
PCV3
  61 
Pol3
ChartChart
  91  95  95  95  95  86  89 
RCV1
 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 271  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 15
From 80 to 89% 3
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
82
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes surviving infants in 2016
DT 6 years; Yes
DTwPHib 3, 4, 5, 18 months; Yes surviving infants in 2015 and 2016
HepB birth; 1, 5 months; Yes
Influenza >=65 years; Yes Elderly with chronic illness, pregnant women, health workers, Haj and other travellers, and other risk groups
IPV 3 months; Yes surviving infants in 2016
Measles 9 months; 6 years; Yes surviving infants in 2016 and 1st year school children
MMR 11, 18 months; Yes From March 2017
OPV birth; 3, 4, 5, 18 months; 6 years; Yes surviving infants in 2015 and 2016 and 1st year school children
Pneumo_conj 2, 4, 12 months; Yes
Td 11-13, 16-18 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  No  Yes  Yes  Yes  Yes   
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 271  271  271         

System performance

Total Nº districts in country number 271  271  271  271  271  271  271 
Nº districts with DTP3 coverage >=80% number 48  48        44  193 
% of districts with DTP3 coverage >=80% From 0 to 100% 18  18        16  71 
Nº districts with measles (MCV1) coverage >=95% number 27  21        81 
% of districts with MCV1 coverage >=95% From 0 to 100% 10        30 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes    Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes    Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100      100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.